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We examined the regulation of cellular retinol-bind-
ing protein (CRBP) mRNA and protein expression in 
human skin in vi11o by all-tvaus retinoic acid and 
all-trans retinol. Treatment of human skin for 24 h 
with all-tram retinoic acid (0.1 %) or all-trans retinol 
(1.6%) induced CRBP mRNA 5.5-fold (p < 0.01, n = 
10) and 5.7-fold (p < 0.01, n = 5), respectively, 
compared with skin treated with vehicle or sodium 
lauryl sulfate (used as an irritant control). Iu vitro 
translation of poly A+ RNA from all-tra11s retinoic 
acid, all-trans retinol, sodium lauryl sulfate, and ve-
hicle-treated human skin demonstrated that the ob-
served increased CRBP mRNA in all-trans retinoic 
acid- and all-trans retinol-treated skin was able to 
direct increased (2.3-2.9-fold) CRBP protein synthe-
sis. Riboprobe itt situ hybridization revealed that 
CRBP mRNA was uniformly elevated throughout the 
epidermis and in dermal cells after all-traJtS retinoic 
acid treatment of human skin. Western analysis re-
vealed that CRBP protein was elevated 3.2-fold (p < 
0.01, n = 6) and 3.0-fold (p < 0.01, n = 6) after 
C ellular retinol-binding protein (CR.BP) is a ubiqui-tously expressed 15 .8-kDa cytosolic protein that binds all-/ralls retinol (vitamin A) with high speci-ficity and affmity. A highly homologous pwtein, CRDPTI, which is encoded by a di stinct gene, is 
expressed in intestine [1 ,2] . CRBP is a member of a large f.unily of 
fatty acid binding proteins and is believed to be critical for cellular 
uptake and m etabolism of all-trails retinol. Al1-tra11s retinol is carried 
in the circulation bound to retinol-binding protein [3] . All-tra 11s 
retinol dissociates from retinol-binding protein and presumably, 
beca use of its lipophilic nature, enters cells by diffusion through the 
plasma membrane. ln the cytoplasm, all-trttt1s retinol is bound by 
C RBP. In the ce!J , CR.BP-bound all-tm 11s retinol can undergo at 
least two dilfercnt m etabolic fates: it may be either esterified to 
retin yl esters or oxidized to all -tmus retinoic acid . R etinyl esters are 
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all-trans retinoic acid treatment of human skin itt vivo 
for 24 and 96 h, respectively, compared with vehicle-
and sodium lauryl sulfate-treated skin. In addition, 
functional CRBP levels measured by eHJall-tmus 
retinol binding were elevated 1.9-fold (p < 0.01, n = 
6) and 3.5-fold (p < 0.01, n = 6) at 24 and 94 h, 
respectively, after all-t1•ans retinoic acid treatment, 
compared with vehicle- or sodium lauryl sulfate-
treated skin. Gel mobility shift analysis revealed that 
retinoid receptors in nuclear extracts from human 
skin formed a specific complex with a DNA probe 
containing the retinoic acid response element in the 
mouse CRBP gene. Monoclonal antibodies to nuclear 
retinoid receptors demonstrated that predominandy 
retinoic acid receptor-a/retinoid X receptor-a het-
erodimers bound to the CRBP retinoic acid response 
element. These data demonstrate that CRBP expres-
sion in human skin iu vivo is regulated by exogenous 
all-trans retinoic acid and all-trans retinol. Key words: 
Epidermislge11e regu.lation/retiuoic acid ·recepto1•slretillol me-
taiJOlism. J Iuvest Dermatol 105:80-86, 1995 
believed to be the m;Uor storage form of all-tra11s retinol , whereas 
reti.noic acid is a ligand for nuclear re tinoic acid receptors, which 
regulate transcription of specific genes. 
CRBP is positively regulated by all-lra11s retinoic acid and 
negatively regulated by glucocorticoids [4- 8]. Evidence indicates 
that regulation by all-tmns rctin oic acid is primarily transcriptional 
and is m ediated by nuclear re tinoid receptors [9, 1 0] . These recep-
tors are members of the steroid/thyroid hormone supergene family 
of nuclear receptors. M embers of this family characteristica ll y bind 
both specific DNA sequences (response elements) in targe t gene 
promoters, and hormones. H ormone binding results .in receptor 
activation which , in conjunction with other transcription factors , 
results in enhancement or reduction in the rate of gene transcrip-
tion . Functional retinoic acid response cleme nts (RAREs) have 
been identified in the rat [9] and mouse [10] CR.BP gene promot-
ers. T hese R.AR.Es are composed of two 6 -base-pair (bp) repeating I 
motifs separated by 2 bp . T here are two families of nuclem· retinoid 
receptors: nuclear retinoic acid receptors (RAil...s) m1d nuclear 
retinoid X receptors (RXR.s), each encoded by three genes, a, {3, 
and ')I [11-14) . Accumul ating evidence indicates that a\1-l'ra /JS 
re tinoic acid binds to and activates H.A.Rs, which bind to DNA and 
function primaril y as heterodimers with RX R [9,15-20] . It has 
been demon strated i.n transient transfection studies that R.Al 
0022-202X/95/S09 .50 • SSDI0022-202X(95)00206-2 • Copyright © 1995 by The Society fo r Investigative Dermatology, Inc. 
80 
VOL. I 05, NO. 1 JULY 1995 
RXR h eterodim ers bind to and transactivate h eterologou s reporte r 
constru cts containing the CRBP RAitE [9,10]. 
Retinoic acid is vital to the maintenance of cellul ar h omeostasis 
in adult mammalian skin . Dietary all-trans retinol deficiency results 
in altered epiderm al differentiation (hype rkeratosis), in which the 
skin becomes thin and scaly because of reduced cellular growth and 
increased tem1inal differentiation [21] . T lJ.i.s condition ca n be 
reversed by adm inistration of eithe r all-trans retino l or all-tra ns 
reti.noic acid. Because all-trarrs rctinoic acid is formed from all-tnws 
retinol, it h as been concl uded that retinoic acid is essential for 
normal skin function. We have previously reported that topical 
treatment of adult human skin with all-trans retinoic acid results in 
a variety of cellula r and biochemical alterations [22- 25]. In addi-
tion, we and others have previously demonstrated that adult human 
skin expresses RAR and RXR transcripts and proteins [14,26-29). 
Based on these data, we hypothesize th at CRBP expression in 
hl1111an skin is regulated by all-trans retinoic acid . To test tlJ.i.s 
hypothesis, we determined CRBP mRNA and protein levels in 
human epidermis after topical all-trans retinoic acid treatment. 
MATEIUALS AND METHODS 
Materials Reagents for [32P]labeling DNA probes for Northern analysis 
and gel retardation assays, and fo r labeling and detecting digoxjgenin-
labeling cRNA probes for i11 situ hybridization, were o btained from 
Boehringer Mannheim. O ligo (dT) 2 5-coupled magnetic beads (Dynabeads) 
were from Dynal , Inc. Wheat germ extract for in vitro translation was fi·om 
Promega. Oligonucleotides were synthesized by the DNA synthesis facil ity, 
University of Michigan . eHJall-1rn11s retinol and [a·- 32PJ-dCTP (3000 
Ci/mmol) were purchased from DuPont New England Nuclear. Human 
multiple tissue poly A+ RNA blot was obtained from C ion tech. Human 
CRBP eDNA and antibodies were generously provided by Dr. William S. 
Blaner (Institute of Human Nutrition , Columbia University, New York). 
Horseradish peroxidase-conjugated goat anti-rabbit lgG was from Cappel 
Researcb Products. Enhanced chemiluminescent detection reagent w as 
from Amersham Corporation. Ammonyx LO (N,N-dimethyl-dodecylam-
ine-N-mddc) was obtained from Flu ka C hemika. Zeta Probe nylon mem-
brane for Northern analysis was fi0111 Bio-Rad. 
Procurement of Human Skin Biopsy Specimens All-trailS retinoic 
acid cream (0.1 %), the skin irritant sodium Iaury! su lfate (SLS; 2'Xt in all-t ra 11s 
retinoic acid cream), and vehicle cream were app lied to the buttocks of 
healthy ad ult volunteers [22]. In separate experiments, subj ects were treated 
topically with all-tra11s retinol (1 .6% dissolved in 95% ethanol/propylene 
g lycol, 7:3, containing 0.1 mg/ ml butylated hydro>.]' toluene as antioxidant) 
and vehicle. Treated areas were covered with light-tight plastic wrap to 
prevent surf.1ce loss and oxidation and to enhance penetration of com-
pounds into the shln. After 6, 1 6, 24, or 96 h of n·eatment, keratome biopsy 
specimens were ob tained from treated sites as described previously [22]. ln 
addition, fu ll-thickness 4- mm punch b iopsy specimens from all-1ra11s reti-
noic acid and vehicle- treated shln were obtained fo r i11 sit11 hybridizatio n 
studies . A ll procedures in vo lving human subjects were approved by the 
University of Michigan Institutional Rc,riew Board , and all subjects pro-
vided written informed consent. 
Preparation of Nuclear Extracts From Human Skin Nuclear ex-
tracts containing retinoid receptors were prepared from keratome biopsy 
specimens as described previously [28,30]. Extracts were aliquoted and 
stored at - 70°C befOre use. 
Electrophoretic Mobility Shift Assay Gel m obil ity shift assays were 
performed as described by Garner and Revzin 131 ] and Smith t't a/ [l OJ . 
Double-stranded oligodeoxynucleotides containing the RARE (shown in 
bold) in the mouse CRBP promoter (5' -GATCCAGGTCAaaAAGTCA-
GACAC-3 ') [1 OJ were used as probe. For antibody supcrshi fts, we used 
monoclonal an tibodies to RAR-a, AB9u.(F) (9 c•- 9A6) 132]; RAil-)', 
AB4yhF (4y- 7A 11) (33]; and RXR-a, 4RX-1 F6. Radioactive protein-
DNA complexes in the gels were visualized by Phosphor lmager (Molecular 
Dynamics). 
Northern Analysis Total RNA was iso lated fro m keratome biopsy 
specimens by guanidinium hydrochloride lys is and ul tracentrifugation, as 
described previously [34] . Equa l quantities (20 J.Lg per lane) of total RNA 
were separated electrophoretica l.Jy in 2.2 M fonnaldehyde, l 'Y., agarose gels, 
transferred to nylon membranes, and hybridized with randomly primed 
['2 P]labeled eDNA probes for CRBP or 36B4 (36B4 encodes a ribosomal 
protein and was used as an internal control). Visualization and quantitation 
of mRNA levels were performed using a Phosphorlmager. 
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l11 V iti'O Translation Oligo(dT)25-1abeled Dynabeads were used to 
purify poly A+ RNA fi·om tota l RNA derived from human shln treated 
with all-trails retinoic acid (0. 1 °/.,), all-trmts retinol (1 .6%), SLS (2%), or 
vehicle before biopsy. Poly A + RNA (2 J.Lg) fiom each treatment group was 
translated using the whea t germ extract system according to the manuf.1c-
turer's .il1 struc6ons. The reaction 111ix turcs containing the translated protein 
products (.1 00 J.Lg protein) were separated by sodium dodecylsulfute-
polyacrylamide gel e lectrophoresis (SDS-PAGE), transferred to nitrocellu-
lose membrane, and subjected to Westem b lot ana lys is, as described below. 
Western Analysis CRBP prote in levels were determined in high-speed 
supernatants, prepared as described below, from vehicle- treated, SLS-
treated, and all-lratJs retinoic acid-treated shln. Samples (1 00 J.Lg) were 
separated by 15% SDS-PAGE, transferred to nitrocellulose membrane, and 
incubated fo r 16 h with polyclonal rabbit anti-CR.BP antibodies [35] . 
Immunoreactive CRBP was visualized by enhanced chemiluminescence 
detection. Band in tensities w ere determined by laser densitometry . 
Measurement of CRBP Levels by Ligand Binding CRBP levels were 
dete rmined in high- speed supernatants fi·om vehicle- treated, SLS-treated, 
and all-trails retinoic acid-treated shln samples by measurement of [31-l]all-
trans re tinol binding. Keratome biopsy specimens were ground to a fine 
powder in liquid nitrogen using a mortar and pestle; homogenized in 20 
mM T ris, pH 7.4, containing 1 mM dithiothreitol and 1 mM phenylmeth-
ylsul fo nyl fluorid e, using a glass homogenizer; and centrifuged at 100,000 X 
g at 4°C for 1 h. T he supernatant was assayed for [3 H]all-traus retinol 
binding. [3 H]all-traiiS retinol (SO pmol, 200,000 cpm) in ethanol was 
transferred to microcenn;fuge tubes, and the solvent was evaporated with a 
stream of nitrogen gas. Dried all-1ra11s retinol was dissolved in 2 J.L! 
Ammonyx LO, followed by addition of 848 J.Ll assay buffer (20 mM 
T ris-HCJ, 10% glycerol, 10 mM thioglycerol , pH 7.5) and .150 J.Ll sample 
(100 J.Lg protein) . After incubation of the m ixrures in the dark at 4°C fo r 16 
h , 0.5 ml 3% dextran-coa ted charcoal [36] was added for 30 min on ice to 
adsorb free all- tra il.\' retinol. Charcoal was rem oved by centrifugation for 5 
min at 10,000 X g, and aliq uots of the supematants, containing ['H]all-tralls 
retinol bound to CIU3P, were counted in a liqwd sc intillation counter. 
Iu Situ Hybridization T he blucscript plasmid conta ining human CRBP 
eDNA was linearized w ith Hhtdiii or Pstl for sense and anti-sense probes, 
respecti vely. Digoxigenin-con tainin g sense and anti-sense cRNA probes 
were synthesized by i11 JJitro transcription using T3 and T7 RNA poly-
merases . Frozen sec tions (5 J.Lm thick) were thaw-mounted onto slides 
coated with 3-aminopropyl-triethoxysilane . fixed with 4% (w/ v) paraform-
aldehydc, treated with 0.2 N I-ICI for 5 min at room temperature, and 
subjected to proteinase K digestion (5 J.Lg/ m l) at J 7°C for 5 min, fo llowed 
by a second fixation with 4% paraformaldehyde. After rinsing in phosphate-
buffered sa line, the slides were acerylatcd with 0.25% (v/v) acetic anhydride 
in 0.1 M triethanolamine, pl-1 8.0, rinsed in nuclease-free water, and 
equi librated in 10 mM Tds-HCI (pH 7.5), 50% formamidc, 0.6 M NaCI, 1 
mM ethylcnediam inctetraacctic acid, 10 mM d ithioth reito l, and 50 }.Lg/ ml 
heparin . Prehybridiza tio u was perfonned for 1 h at 50°C iu equilib ration 
buffer, to w hich 10% polyethylene glycol 7500 and 1 X Denhardt's solution 
were added. Hybridization was performed for 18 h at 50°C in prehybrid-
ization bufFer, to w hich 0 .5 mg/ m l denatured salmon sperm DNA, 0.5 
mg/ml ye:~ st tR.NA, and ·1 J.Lg/ml sense or anti-sense cRNA probes were 
added . Sectious were washed o nce after hybridiza tion in 2 X sodium 
citrate/sodium chlmide buffer (SSC) for 30 min at 50°C, digested with 
l~ase A (20 J.Lg/ml) for 30 min at 37°C, and washed for 30 min in 2 X 
SSC/50% formamid e/10 mM dithiothreitol at 37°C and twice in 1 X 
SSC/ .1 4 mM dith.iothreitol/0.067% sodium pyrophosphate at 50°C for 30 
min . H ybridization signals were detected immunoh.istochemica.ll y using 
alkaline-phosphatase-conjugated an ti-digoxigenin antibody. 
Protein Assay Protein concentration was meas ured by the Pierce/BCA 
n1cthod using bo vine serurn albun1in as standard [3 7]. 
Statistical Analysis Comparisons of CRBP induction between treat-
ment groups were performed with eid1er the paired t test or repeated-
measures aual ys is of va riance with the T ukcy procedure for multip le group 
cornparisons . Sun1n1ary statistics arc expressed as ntean :!:: SEM. Data 
ana lysis was perfonned usiug the Michiga n Data Analysis S)'Stem (MIDAS) , 
a statistical software package developed at the Center for Statistical 
Consu ltation and .Research at the Un.iversity of Michigan . 
RESULTS 
Induction ofCRBP Gene Expression by All-Tmus Retinoic 
Acid and Al1-Tm11s Retinol in Human Skin To investigate 
th e regulation of CRBP gene expression in human skin, adult 
subjects were treated top icaJJy w ith aJI-trnus re tinoic acid c ream 
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24 Hours 96 Hours Treatment 
F igure 1. A11-ll'a11S retinoic acid in-
duces CRBP mRNA in human 
skin . Adult human subjects were 
treated topically with vehicle, SLS 
(2%), and all-1rn11s retinoic acid (RA, 
0.1 %) (e"ch subject was treated on sep-
arate areas with each of the three 
agents) . Keratome biopsy specimens 
were obtained after 24 h (ope11 bnrs) or 
96 h (slwdetl bnrs) of treatment, and 
steady-state levels of CR.BP mRNA 
and 36B4 mRNA (used as an in ternal 
control) were analyzed by Northern 
blot. Top, representative Northern blot 
(20 /-Lg total RNA per lane) resul ts from 
three subjects; V, vehicle; S, SLS; R , 
all-rrn 11s retinoic acid. Bnrs indicate 
mean :!: SEM (n = 1 0) of C R.DP 
mR.NA band intensities nonnalized to 
those of 36B4 mR.NA, determined by 
Phosphorlmagc r. For 24 h treatment 
(n = 1 0): RA versus vchick, p < 0.01; 
RA versus SLS, p < 0.01 ; vehicle ver-
sus SLS, not significant. For 96 h treat-
ment (n = 1 0): Tt.A versus vehicle. p < 
0.05; R.A versus SLS, p < 0.05; vehicle 
versus SLS, not signifi cant. 
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(0 .1 '!lo) , SLS (2%), or vehicle for 6, 24, and 96 h an d determined 
steady- state CR .. BP mRNA levels (normalized to the intemal 
con trol 36134 gene transcript) by N orthe rn blot. Because all-trarrs 
retino ic acid treatment ca uses some skin " irritation" (i. e ., th e skin 
b ecomes pink), treatment w ith the in·itant SLS, which causes a 
sin1il"ar degree of pinkness [22], served as a control for th e effects of 
in;tation. ln all skin samples, a sing le 0. 7-kb CRBP transcript wa s 
d etected. After 6 h of treatment, th e level of CRBP m.R..NA was 
similar in all-trnr1s re tinoic acid-treated , SLS-treated, and vehicle-
treated sian (data no t shown) . ln contrast, a fter 24 h of all-trar1s 
re tinoic acid treatment, CRBP mRNA was increased 3.2-fo ld (p < 
0.01, n = 10) compared with SLS-treated skin and 5.5-fold (p < 
0.01, n = 10) compared with vehicle-treated skin (Fig 1). T h ere 
was no difference between SLS-treated and v ehicle-treated skin . 
Induction of CRBP by all-tra11s re ti noic acid observed at 24 h 
pe rsisted for at least 96 h . After 96 h of treatmen t, CRBP mRNA 
was e leva ted 3.5-fo ld (p < 0.05, n = 10) compared with SLS-
treatcd skin and 2.6-fold (p < 0.05, n = 1 0) compared with 
v ehicle-treated skin (Fig 1). 
We next examin ed whether all-/ralls retinol, the ligand for 
CRBP, could induce CRBP gene expression in human skin . Adult 
subjects were treated topically with aU-trails retinol (1.6"!.,) or 
vehicle for 24 h , an d CRBP mRNA was quantified by Northern 
blot as described above . All-trarrs re tinol induced CRBP mRN A 
5. 7-fold (p < 0.01, n = 5), compared with vehicl e (Fig 2). T h e 
m agnitude of th is induction was similar to that observed with 
all-trans retin o ic acid trea tment (Fig 1). 
CRBP In Situ Hybridization in Human Skin Having dem-
o nstrated indu ction of CRBP mRNA by all-trans re tinoic acid , w e 
next pe rfom1ed i11 sitrr hybridization to localize C RBP transcripts in 
hum an skin treated for 24 h with all-rnms retin oic acid (0.1 %) o r 
veh icle. ln vehicle-treated skin, CRBP mRNA expression w as 
detectable at a low level throughout the epide rmis, with som ewhat 
more inte nse, patchy expression in the lower layers of epid ermis 
(Fig 3A). No sign ificant CRBP expression w as de tected in th e 
dermis. In all-lrarrs retinoic acid-treated skin , CRBP mRNA ex-
pression was elevated throughout the epidermis in a diffuse manner 
(Fig 3B). CRBP transcripts were a.l so present in perivascular 
inflammatory cells, endothe lia l cells, spindle-shaped ce l.l s in th e 
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Figure 2. All-trans retinol induces CRBP mRNA in human skin. 
Ad ul t human subjects were trea ted topica lly with all-/milS retinol (1.6%) and 
vehicle for 24 h. Keratome biopsy specimens were obtained, and steady-
state levels ofCRDP mR.NA and 36134 m.l\.NA (used "San in ternal control) 
were analyzed by Northern blot. Top, representative Northern blots of 
lt.NA (20 1-Lg total l't.NA per lane) from three subjects; V , vehicle; R , 
all-trn 11s retinol. Bnrs indicate mean :!: SEM fold change relative to vehicle 
treatment of CR.B P mRNA band intensities, normalized to those of 36B4 
mR.NA, determined by Phosphorlmagcr. Vehicle versus all-trn11s retinol : p 
< 0.01. n = 5. 
VOL. 105, NO. 1 JULY 1995 
Figure 3. Localization of CRBP mRNA in vehicle-treated and all-
tra11s retinoic acid-treated human skin by ;,. situ hybridization. Adult 
human subjects were treated with vehicle and all-tm11s retinoic acid (0 .1 %) for 
24 h. Full-thickness 4-mm specimens were obtained, embedded in OCT, and 
frozen in liquid nitrogen. Cryostat sections (5 J.Lm) were hybridized with sense 
or anti-sense CRBP riboprobes, as described in Matedals a11d Methods. A, 
vehicle-treated skin witb anti-sense probe: B, all-tra11s retinoic acid-treated skin 
with anti-sense probe; C, all-tmm rctinoic acid-lTcatcd skin with sense probe. 
Results are representative of four experiments d1at yielded similar results. 
dennis, cells in the hair follicles, sweat glands, and ducts. Hybrid-
ization of all-tmus retinoic acid-treated skin with a sense CRBP 
cRNA probe (Fig 3C) yielded no de tectable signal, indicating that 
hybridization of the anti- sense probe was specific. 
I11 Vitm Translation of CRBP mRNA From All-Tm11S Reti-
noic Acid-Treated, All- Tmus Retinol-Treated, SLS-
Treated, and Vehicle-Treated Human Skin To determine 
whether increased CRBP mRNA observed in all- trans reti.noic 
acid-treated and all-trans retinol-treated skin could direc t increased 
CRBP protein sy>1thesis, we performed iu IJitro translation of equal 
amounts ofpoly A+ RNA isolated from human skin treated with 
aU-trans retinoic acid (0.1 'Yo), all-trnus retinol (1 .6%), SLS (2%), and 
vehicles for 24 h. Levels of CRBP protein and RAR-yl protein 
(used an internal control) synthesized in IJitro were determined by 
Western blot. The level of CRBP protein synthesized with poly 
A+ RNA obtained from all-trnus retinoic acid-treated and all- traus 
retinol-treated skin was elevated 2.3 -fold and 2.9-fold, respec-
tive ly, compared with that obtained with vehicle-treated skin (Fig 
4). There was no difFeren ce in the level of CRBP protein synthe-
sized with poly A+ RNA isolated from vehicle-treated versus 
SLS-treated skin (Fig 4). To examine the specificity of the observed 
increase in CRBP protein sy>1thesis with all-tra11s retinoic acid and 
al1-tra11s re tinol treatment, and to perform an internal control, w e 
detennined the leve l of RAR-y1 protein synthesized i11 IJitro . We 
chose to measure RAR-yl beca use the level of its transcript does 
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not vary under the conditions of ueatment (data not shown). In 
contrast to CRBP, as e;-.:pected, the level of nuclear RAR-')'1 
protein synthesized i11 IJ itro did not differ among the four trea tm ent 
groups (Fig 4) . These data indica te that increased CRBP mRNA 
levels in all-trmiS re tinoic acid-treated and all-tm11s retinol- treated 
skin can direct increased CRBP protein Sy>1thesis. 
Measurement of CRBP Protein Levels and All-Tmns Reti-
nol Binding Activities in All-Tmus Retinoic Acid-Treated, 
SLS-Treated, and Vehicle-Treated Human Skin The above 
data demonstrate that all-tm11s retinoic acid and a.ll- tra11s retinol induce 
CRBP mRNA in human skin i11 11i1' 0 and that the increased CR.BP 
mP..NA is capable of directin g increased CRBP protein synthesis i11 
IJitro . W e next examined whether the observed increase in CRBP 
mRNA after all-tra11s retinoic acid treatment of human skin i11 IJivo 
resulted in increased CRBP prote in con tent and increased all-trn11s 
retinol binding activity. Westem analysis revealed that after 24 h of 
all-tra11s retinoic acid treatment, CRBP protein was elevated 3.0-fold 
(p < 0.01 , n = 6) compared vvid1 SLS- treated skin and 3 .2-fold (p < 
0.01 , n = 6) compared with vehicle- treated skin (Fig 5). SinUla.r 
results were obtained after 96 h of al.l-trmrs retinoic acid treatment. 
CRBP protein was increased 2.8-fold (p < 0.01, n = 6) compared 
wid1 SLS- treated skin and 3.0-fold (p < 0.01, n = 6) compared with 
vehicle-treated skin (Fig 5) . There were no differences in CRBP 
protein levels, at either 24 or 96 h of treatment, between SLS- and 
vehicle-treated skin (Fig 5). 
We next determined aJ1-tra11s retinol binding, a m easure of 
fu nctional CRBP protein, in supematants from all-trans retinoic 
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Figure 4. Increased ;,. rlitr·o translation of CRBP mRNA in all-tr·ans 
retinoic acid-treated and all-tr·a11s retinol-treated human skin. Poly 
A+ RNA was isolated from human skin treated for 24 h wid1 vehicle (Veh), 
SLS (2'Yo), all-traus retinoic acid (RA, 0. t 'Y.•) , and all-trailS retinol (ROL, 
1.6%), and translated ;, 11itro (2 J.Lg poly A+ RNA) using wheat gem1 
extract. Translation products (t 00 J.Lg total protein) were resolved by 
SDS-PAGE and immunoblotted with antibodjes specific to CRBP and 
It.AR-y. Bar graph djsplays relative CRBP/ RAR-y band in tensities , deter-
rniued by laser dcnsitontc try. Data arc representative of tw·o exp eriments 
that yielded similar results. 
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Figure 5. All-tvatts retinoic acid induces CRBP protein in human 
skin in 11i11o. Adult human subjects were treated topicaUy with vehicle, SLS 
(2%>), and a.ll-rra11s retinoic acid (RA, 0.1%) (each subject was treated with 
each of the three agents) for 24 h (o[Jell ban·) or 96 h (s haded bars). CRBP 
protein levels in high-speed supernatants were determined by Western blot. 
Top, Western blot results from three individuals treated with vehicle (ln11es 
1,4, 7), SLS (/a11e.r 2,5,8), and retinoic acid (ln 11es 3,6,9) for 24 h (A) and 96 
b (B). L.n11e 10 is purified rat testes CRBP standa.rd . Bnrs indicate mean :!: 
SEM fold change relative to vehicle treatment of CR..BP protein band 
intensities, determined by laser densitometry. For 24 h treatment (n = 6): 
H .. A versus vehicle, p < 0.01; R.A versus SLS. p < 0.01; vehicle "'"·sus SLS, 
not significant. For 96 h treatment (n = 6): RA versus vehicle, p < 0.01; 
RA versus SLS, p < 0.01; vehicle ve rsus SLS, not significant. 
acid-treated (0.1 %), SLS-treated (0.2'!/o), and vehicle- treated skin. 
After 24 h of all.-tmtts retinoic acid treatment, all-trans retinol 
binding activ ity was elevated 2.0-fold (p < 0.0], n = 6) compa~·ed 
with SLS-treared skin and 1.9-fold (p < 0.01, n = 6) compared 
with vehicle-treated skin (Fig 6). Similar results were obtained after 
96 h of all-trn11s retinoic acid treatment. All-trn11s retinol binding 
activity was increased 2.5-fold (p < 0.01, n = 6) compared with 
SLS-treated skin and 3 .5-fotd (p < 0.01, n = 6) compared with 
vehicle- treated skin (Fig 6). There were no differences in all-trans 
retinol binding activity, at either 24 or 96 h of treatment, between 
SLS- and vehicle-treated skin (Fig 6) . 
Binding ofRetinoid Receptors in Human Skin to the RARE 
in the CRBP Gene The above data demonstrate that all-tra11s 
t·etinoic acid induces CRBP mRNA <~nd protein expression in 
human skin. To delin eate further the mechanism of CRBP induc-
tion, we investigated whether retinoid receptors in human skin can 
bind to the RARE in the CRBP gene. The RARE element in the 
CRBP gene in mouse and rat is composed of direct repeats of two 
hexameric ha lf sites spaced by 2 bp (DR-2) . This motif binds 
nuclear retinoid receptors and is responsible for stimulation of 
CR.BP gene transcriptioiJ by aU-tra ils retinoic acid [9,1 OJ. Because 
the human Cl"l..BP gene promoter has not been sequenced, we 
examined the interaction ofhuman skin retino id receptors with the 
RARE in the mou se Cl"l..BP gene . 
Electrophoretic mobility shift assays revealed that nuclear ex-
tracts from human skin formed a retarded complex with a synthetic 
double-stranded (32P]deoA.-ynucleotide probe containing the mouse 
CR.BP gene RARE (Fig 7 , laoe 1). Addition of 1 00-fold excess 
unlabeled probe effectively reduced the intensity of the complex, 
indicating that it was specific (Fig 7, lane 2) . To identify which 
retinoid receptors in skin bind to the CRBP RARE, we performed 
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Figure 6 . All-trarrs rctinoic acid induces CRBP binding activity in 
h uman skin irr rdvo. Adult human subjects were treated topically with 
vehicle, SLS (2%), and all-trnrrs retinoic acid (RA , 0.1%) (each subject was 
treated with each of the three agents) for 24 or 96 h. ["HJretinol binding by 
CR..BP was determined in high-speed supernatants as described in J\l!areo·ials 
t111d Methods. Bars indicate mean :!: SEM fo ld change relative to vehicle 
treatment of CRBP binding activity. Values for vehicle-treated skin were 
0.17 :!: 0.01 and 0.09 ::!:: 0.02 pmol retinol bonnd/mg protein at 24 and 96 
h, respectively. For 24 h treatment (n = 6): RA versus vehicle, p < 0.01; 
RA versus SLS, p < 0.01; vehicle versus SLS, not sign.ificant. For 96 h 
treatment (n = 6): ll..A versus vehicle, p < 0.01; RA versus SLS, p < 0.01; 
vehicle versus SLS, not significant. 
supershift gel retardation assays with monoclonal antibodies specific 
for RAR-a, R.AR- ,13, l,~R-y, and iUCR-a. A faint but detectable 
supershifted complex was obtained with antibody to RAB. .. - a (Fig 
7 , lane 3). Intense supershifted complexes were obtained with 
antibodies to RAR- y (Fig 7, lane 4) and RXR- a (Fig 7 , la11e 5) . 
Antibodies to RAR-)1 and RXR-a together double supershifted 
essentia ll y all. of the retarded complex (Fig 7 ; compare l.aues 1, 6). 
No shifted complex was observed with antibody to R..AR- ,13 (data 
not shown). These data demonstrate that R.AR.- y and RXR-a are 
the predominant nuclear retinoid receptors in human skin that bind 
to the CRBP RARE. 
DISCUSSION 
This study demonstrates that topical application of a11 - trnns retinoic 
acid or aU- tra ns re tinol induces Cl"l..BP expression in adult huma.n 
skin. T hese results are consistent with previous studies demonstrat-
ing induction of CRBP mRNA by aU- trans retinoic acid and/or 
all -trailS retinol in the lung of retinol-sufficient [7) and -deficient 
(5,38] rats, cultured Sertoli cells [39], and P19 embryonal carci-
noma cells (40]. Although the mechanism of CR.BP induction in 
human skin by retinoids remains to be el ucidated, one likely 
possibility is that it involves nuclear retinoid receptor-mediated 
transcriptional activation of the CRBP gene. Although the pro-
moter of the human CJ"l..BP gene has not been sequenced, both the 
mouse [1 0) and rat [9] Cl"l..BP genes contain l~REs that specifically 
bind nuclear retinoid receptors and confer aiJ-tralls retinoic acid 
inducibi lity on Cl"l..BP promoter reporter gene constructs. In gel 
mobility supershift assays with nuclear extracts from huma11 skin, 
we found that R..AR-y/RXl~-0' heterodimers, which are the rnajor 
retinoid receptors in human skin [28], bound to the mouse CR.BP 
RARE. These data are compatible w ith the involvement of RAR-
y/1~-a heterodimers in mediating CRBP gene induction by 
all-trails retinoic acid in human skin. More direct evidence for this 
m echanism must await sequencing of the human CR.BP gene. 
We observed that all - trans retinol, in addition to all-trails retinoic 
acid, induced CRBP expression in human skin. Induction of CRBP 
by all-trans retinol presumably reflects its conversion to all-trm1s 
retinoic acid (reviewed in [41]). We (42] and others [43,44] have 
demonstrated the capacity of cultured human keratinocytes to 
synthesize all-trn11s retinoic acid from all-trails retinol. We have also 
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Figure 7. Nuclear retinoid receptors in human skin bind to the 
CRBP RARE. B indi11g of retin oid receptors Ul nuclear e xtrac ts fi·o m adul t 
human ski n to th e RARE in th e m ouse C R.B P gene was assessed by the g el 
shift assay, as descr ibed u1 Materia ls ami Metlwrls. Tria11glc 1, la11e 1, specific 
complex ofCR.BP-R.ARE with human skin nuclear retinoid receptors; la11e 
2, comp e titio n of specifi c DNA binding with I 00-fold excess unlabeled 
probe; tria 11gle 2, la11e 2, supc rsh.iftcd complex with m o noclonal an tibody to 
R.AR.-a; tria11gle 2, la11e 3, supershi fted complex with m o n oclon al an t ibod y 
co R.AR.-y; tria11gle 4, la11 e 4, supc rshiftcd complex w ith m o n oclonal 
an tibody to R X R.-a; tria11gle 3, la11e 5, doublc- supershi ftcd complex with 
antibod ies to R.AR-y and R.X.R-a. R.esults arc represen tative of tltrce 
experiments th at yielded similar results . 
demonstrated in cultured human keratinocytes that transcriptio nal 
activation by all-/ralls retinol of a RAR-dependent reporter gene, 
under the control of a RARE, is inhibited by citra! , which blocks 
the m etabolic conve rsion of all-/rallS retinol to all-tra11s retinoic acid 
[ 42] . Thus, we hypothesize that all-trans retino l-induced C RBP 
expression, and likely the majori ty of other biologic responses of 
the skll1 to all-lm11s retinol, are m ediated through nuclear retino id 
receptors, subsequent to the m e tabolic conversion of aU-trailS 
retinol to all-trans retinoic acid . 
Accumul ating evidence indicates that C IU3P plays a critical role 
in cellul ar uptake and meta bolism of all-lmns retinol (reviewed in 
[45,46]) . T he ratio ofapo- CRBP to holo-ClU3P appears to be a key 
determinant in regula ting the relati ve rates of re tinyl ester synthesis 
and hydrolysis. T hus, unde r conditi ons of relative retinol insuffi-
ciency (i.e ., apo-CRBP greater than ho lo- CRBP), net all-trans 
retino l esterification is reduced in favor of all-1ra11s retinol oxidation 
to all- trnus retinoic acid, which also uses hol o-CRBP as substrate. 
Because alJ-tmtts retinol .is the precursor of a.U-t rn11s retinoic acid, 
CIU3P INDUCTION IN l·I'UMAN SKIN 85 
induction of CRBP by exogenous all-trn 11s retino.ic acid probably 
reflects, at least in part, a physio logic m echanjsm to promote 
sto rage of all-tm11s retino l as rctinyl esters, under conditions of 
perceived all-lrn11s retinol excess. Indu ction of C IU3P levels by 
exogenous alJ -Im11s retinoic acid m ay the refore have th e potential to 
modulate metabolism of endogenous all-rrn11s retinol. This issue is 
currently under investigation in o ur laboratory. 
T his sutdy was s11ppo11ed i11 pm1 by tile Babcock Ftllld for D ermatological Research. 
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